Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
covid-19
3
×
deals
detroit blog main
detroit top stories
europe blog main
europe top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
3
×
raleigh-durham top stories
san diego blog main
san diego top stories
3
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
3
×
takeda pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alzheimer's disease
amag pharmaceuticals
amgen
astrazeneca
biogen
biontech
What
bio
roundup
acquisitions
buy
ceo
daniel
gilead
o’day
sciences
alliance
announced
biggest
bristol
build
calls
changing
collabs
color
company’s
covid
crispr
days
deal
debut
drug
dyne’s
gilead’s
growing
help
hours
introduce
ipo
kudos
leaves
medicines
microbiome
month
moves
myers’s
notifying
Language
unset
Current search:
startups
×
covid-19
×
" san diego top stories "
×
" raleigh-durham blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More